The human cyclin B1 protein modulates sensitivity of DNA mismatch repair deficient prostate cancer cell lines to alkylating agents

被引：10

作者：

Rasmussen, LJ

Rasmussen, M

Lützen, A

Bisgaard, HC

Singh, KK

机构：

[1] Johns Hopkins Oncol Ctr, Johns Hopkins Sch Med, Baltimore, MD 21231 USA

[2] Roskilde Univ, Dept Life Sci & Chem, DK-4000 Roskilde, Denmark

来源：

EXPERIMENTAL CELL RESEARCH | 2000年 / 257卷 / 01期

关键词：

mismatch repair (MMR); cyclin B1; alkylating agents; prostate cancer; DU145; LNCaP;

D O I：

10.1006/excr.2000.4865

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

DNA damage caused by alkylating agents results in a G2 checkpoint arrest. DNA mismatch repair (MMR) deficient cells are resistant to killing by alkylating agents and are unable to arrest the cell cycle in G2 phase after alkylation damage. We investigated the response of two MMR-deficient prostate cancer cell lines DU145 and LNCaP to the alkylating agent MNNG. Our studies reveal that DU145 cancer cells are more sensitive to killing by MNNG than LNCaP, Investigation of the underlying reasons for lower resistance revealed that the DU145 cells contain low endogenous levels of cyclin B1. We provide direct evidence that the endogenous level of cyclin B1 modulates the sensitivity of MMR-deficient prostate cancer cells to alkylating agents, (C) 2000 Academic Press.

引用

页码：127 / 134

页数：8

共 50 条

[1] Characterization of cyclin B1 expression in human cancer cell lines by a new three-parameter BrdUrd/cyclin B1/DNA analysis
Faretta, M
Bergamaschi, D
Taverna, S
Ronzoni, S
Pantarotto, M
Mascellani, E
Cappella, P
Ubezio, P
Erba, E
CYTOMETRY, 1998, 31 (01): : 53 - 59
[2] Aberrant cyclin B1 expression in human tumors and cell lines
Yu, M
Zhan, QM
Finn, OJ
FASEB JOURNAL, 2001, 15 (05): : A1206 - A1206
[3] Selective sensitivity to carboxyamidotriazole by human tumor cell lines with DNA mismatch repair deficiency
Yang, Jia-Lin
Qu, Xian-Jun
Yu, Yan
Kohn, Elise C.
Friedlander, Michael L.
INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (02) : 258 - 263
[4] Differential modulation of chemosensitivity to alkylating agents and platinum compounds by DNA repair modulators in human lung cancer cell lines
Heim, MM
Eberhardt, W
Seeber, S
Müller, MR
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (04) : 198 - 204
[5] Differential modulation of chemosensitivity to alkylating agents and platinum compounds by DNA repair modulators in human lung cancer cell lines
M. M. Heim
W. Eberhardt
S. Seeber
M. R. Müller
Journal of Cancer Research and Clinical Oncology, 2000, 126 : 198 - 204
[6] Global proteome comparison of DNA mismatch repair proficient and deficient colorectal cancer cell lines.
Halvey, Patrick
Slebos, Robbert
Stamer, Sheryl
Liebler, Daniel
CANCER RESEARCH, 2009, 69
[7] Specificity of mutations induced by methyl methanesulfonate in mismatch repair-deficient human cancer cell lines
Glaab, WE
Tindall, KR
Skopek, TR
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1999, 427 (02) : 67 - 78
[8] REPAIR REPLICATION AND UNSCHEDULED DNA-SYNTHESIS IN MAMMALIAN-CELL LINES SHOWING DIFFERENTIAL SENSITIVITY TO ALKYLATING-AGENTS
FOX, M
FOX, BW
MUTATION RESEARCH, 1973, 19 (01): : 119 - 128
[9] Cisplatin tolerance is elevated in mismatch repair deficient prostate cancer cell lines but independent of acquired resistance to irradiation or docetaxel
Donix, L.
William, D.
Erb, H.
Peitzsch, C.
Dubrovska, A.
Thomas, C.
Fuessel, S.
Erdmann, K.
EUROPEAN UROLOGY, 2021, 79 : S609 - S609
[10] DNA mismatch repair protein, PMS2, induces apoptosis in human prostate cancer cells
Fukuhara, Shinichiro
Chang, Inik
Shahryari, Varahram
Gill, Ankurpreet
Wong, Darryn K.
Yamamura, Soichiro
Majid, Shahana
Saini, Sharanjot
Hirata, Hiroshi
Ueno, Koji
Deng, Gouren
Tabatabai, Laura Z.
Nonomura, Norio
Dahiya, Rajvir
Tanaka, Yuichiro
CANCER RESEARCH, 2014, 74 (19)

← 1 2 3 4 5 →